Evidence map›Paper›PMID 39447165›Full record

ArticleJMIR formative research2024

Cadence-Based Pedometer App With Financial Incentives to Enhance Moderate-to-Vigorous Physical Activity: Development and Single-Arm Feasibility Study.

Kosuke Hayashi, Hiromitsu Imai, Ichiro Oikawa, Yugo Ishihara, Hirokazu Wakuda, Iori Miura, Shingo Uenohara, Asuka Kuwae, Megumi Kai, Ken'ichi Furuya and 1 more

Abstract read
In one paragraph

Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kosuke HayashiDepartment of Clinical Pharmacology and Therapeutics, Oita University, Yufu, Japan.ORCID 0000-0003-0093-675X
Hiromitsu ImaiDepartment of Medical Ethics, Faculty of Medicine, Oita University, Yufu, Japan.ORCID 0000-0001-7805-1180
Ichiro OikawaClinical Pharmacology Center, Oita University Hospital, Yufu, Japan.ORCID 0000-0001-8628-2843
Yugo IshiharaDepartment of Clinical Pharmacology and Therapeutics, Oita University, Yufu, Japan.ORCID 0009-0004-5572-4724
Hirokazu WakudaClinical Pharmacology Center, Oita University Hospital, Yufu, Japan.ORCID 0000-0002-5717-8251
Iori MiuraFaculty of Science and Technology, Oita University, Oita, Japan.ORCID 0009-0006-4811-0227
Shingo UenoharaFaculty of Science and Technology, Oita University, Oita, Japan.ORCID 0009-0003-5743-829X
Asuka KuwaeFaculty of Science and Technology, Oita University, Oita, Japan.ORCID 0009-0004-6060-3257
Megumi KaiDepartment of Clinical Pharmacology and Therapeutics, Oita University, Yufu, Japan.ORCID 0009-0000-0024-7212
Ken'ichi FuruyaFaculty of Science and Technology, Oita University, Oita, Japan.ORCID 0000-0002-5407-3673
Naoto UemuraDepartment of Clinical Pharmacology and Therapeutics, Oita University, Yufu, Japan.ORCID 0000-0002-3722-8979

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh levels of physical activity are key to improving health outcomes, yet many people fail to take action. Using pedometers to target steps per day and providing financial incentives is a simple and scalable approach to promoting public health. However, conventional pedometers do not account for "intensity" and "duration," making it challenging to efficiently increase people's moderate-to-vigorous physical activity (MVPA), which is expected to improve health outcomes. Based on these rationales, we developed a smartphone app that sets step cadence as a goal (defined as a daily challenge of walking more than 1500 steps in 15 minutes twice a day, which is a heuristic threshold for moderate physical activity) and provides financial incentive when the challenge is met.

objectiveThis study aimed to evaluate the feasibility of our novel app and explore whether its use can increase users' daily MVPA.

methodsA single-arm pre-post study evaluated the feasibility and efficacy of the app. A total of 15 participants used app 1 (an app without financial incentives) for the first period (4 weeks) and then switched to app 2 (an app with financial incentives) for the second period (4 weeks). The primary outcome was the difference between the first and second periods in the number of successful challenge attempts per week. Secondary outcomes were differences between the first and second periods in daily steps and distance walked. Exploratory outcomes included the difference between the first and second periods in daily "heart points" as measured by Google Fit, a publicly available app that measures users' daily MVPA.

resultsThe number of successful challenge attempts per week increased significantly compared to the first period (5.6 times per week vs 0.7 times per week; P<.001). Although not statistically significant, there was a trend toward an increase in the mean steps per day and distance walked per day (6586 steps per day vs 5950 steps per day; P=.19; and 4.69 km per day vs 3.85 km per day; P=.09, respectively). An exploratory end point examining daily MVPA by "heart points" collected from Google Fit also showed a significant increase compared to the first period (22.7 points per day vs 12.8 points per day; P=.02).

conclusionsOur app using step cadence as a goal and providing financial incentives seemed feasible and could be an effective app to increase users' daily MVPA. Based on the results of this study, we are motivated to conduct a confirmatory study with a broader and larger number of participants.

trial registrationUMIN 000050518; https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000057420.

Indexed as

ExerciseFeasibility StudiesMobile ApplicationsMotivationActigraphyAdultFemaleHealth PromotionHumansMaleMiddle AgedWalkingapparmbehavioral economicscadenceexerciseGoogle Fitheart pointsmobile phonepedometerphysical activitypublic healthwalk

Identifiers

PMID39447165
PMCPMC11544333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.